IPN-01203

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameIPN-01203
Drug Alias NameIPN01203IPN-01203
ClassificationBiologics > T cell engagersBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-T-cell receptorInterleukin-15 receptors modulators
TargetsT-cell receptorInterleukin-15 receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesIpsen
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A